Mobidiag develops and provides industry-leading solutions for in vitro diagnostics of infectious diseases. We make molecular diagnostics fast, accurate and accessible. This improves the quality and efficiency of healthcare, helps prevent the spreading of antibiotic resistances and creates new opportunities for routine diagnostics.

NEW! Anti-SARS-CoV-2 Rapid Test


Mobidiag is now offering a rapid and easy to use immunoassay to detect coronavirus (COVID-19) infection. The Anti-SARS-CoV-2 Rapid Test uses the lateral flow technology and allows detection of IgG and IgM from human serum, whole blood or plasma in about 15 minutes.

Learn more!

Novodiag® is a turnkey, easy-to-use solution, providing rapid and sensitive on-demand results. The fully automated platform is ideal for complementing high-throughput screening solutions enabling immediate detection of infectious diseases when time-to-result is critical.

Amplidiag® is a family of diagnostic tests for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Amplidiag® Easy takes the suite – unmatched in performance and capability – even further by automating the workflow from primary sample to final result.


We work in cross-functional projects and constantly share our knowledge and learn from each other. Our employees are driven by hard work, but this doesn’t stop us from having fun at work and fostering excellent team spirit. We appreciate diversity and believe it should be at the heart of our teams, so we aim at recruiting people from a wide variety of backgrounds and experiences.


Mobidiag’s products are available throughout Europe and we are constantly extending our global distribution networks. If you are interested in learning more about the company and our products or would like to start a test period in your laboratory, please contact us. We are here to help you.

We areMobidiag Logo